Methylation-Specific Assay Detects Advanced Breast Cancer

Share this content:
Genetic Signatures for Cancer are Making Headlines
Genetic Signatures for Cancer are Making Headlines

(HealthDay News) — A methylation-specific 10-gene panel can detect advanced breast cancer and reflects chemotherapy response, according to a study published in the April 15 issue of Cancer Research.

Mary Jo Fackler, PhD, from the Johns Hopkins University School of Medicine in Baltimore, and colleagues developed a quantitative multiplexed methylation-specific polymerase chain reaction assay for a panel of 10 genes (cMethDNA). 

The genes, which included novel and established breast cancer hypermethylated markers, were previously identified in breast tissue, and the panel was validated in The Cancer Genome Atlas project breast cancer methylome database. A fixed physiologic level of artificially constructed standard nonhuman reference DNA specific for each gene was introduced for cMethDNA.

RELATED: Breast Cancer Resource Center

The researchers detected cancer-specific methylated DNA in training (28 normal, 24 cancer) and test (27 normal, 33 cancer) sets of sera from patients with recurrent stage IV cancer. In the test set, sensitivity and specificity were 91% and 96%, respectively. 

In a pilot study involving 29 patients, the assay accurately reflected chemotherapy response. Serum and metastatic tissues collected at autopsy 2 to 11 years after disease diagnosis retained the core methylation signature present in the primary breast cancer.

"Together, our data suggest that the cMethDNA assay can detect advanced breast cancer, and monitor tumor burden and treatment response in women with metastatic breast cancer," the researchers wrote.

Several researchers disclosed ownership interests, including patents, related to the study.

Reference

  1. Fackler MJ, Bujanda ZL, Umbricht C, et al. Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer. Cancer Res. 2014;doi:10.1158/0008-5472.CAN-13-3392.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs